Fresenius Medical Care AG & Co. KGaA FMS
$ 20.05
1.47%
Annual report 2023
added 11-02-2024
Fresenius Medical Care AG & Co. KGaA Income Statement 2011-2024 | FMS
Annual Income Statement Fresenius Medical Care AG & Co. KGaA
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | - | 9.47 B | 20.5 B | 22.4 B | 22.7 B | 30.3 B | 24.7 B | 27.1 B | 22.4 B | 21.7 B | 21.7 B | 21.4 B |
Shares |
- | - | 293 M | 605 M | 605 M | 613 M | 613 M | 611 M | 609 M | 605 M | 608 M | 610 M | 598 M |
Historical Prices |
19.4 | 24.1 | 32.3 | 33.8 | 36.9 | 37 | 49.4 | 38.6 | 38.4 | 37 | 30.7 | 30.1 | 30.5 |
Net Income |
- | - | 1.22 B | 1.16 B | 1.2 B | 1.98 B | 1.28 B | 1.18 B | 942 M | 860 M | 804 M | 897 M | 826 M |
Revenue |
19.5 B | 19.4 B | 17.6 B | 17.9 B | 17.5 B | 16.5 B | 17.8 B | 17 B | 15.3 B | 13 B | 10.6 B | 10.4 B | 9.87 B |
Cost of Revenue |
- | - | 12.5 B | 12.3 B | 12.1 B | 11.4 B | 11.8 B | 11 B | 10.3 B | - | - | - | - |
Gross Profit |
- | - | - | - | 5.4 B | 5.15 B | 6.02 B | 5.5 B | 4.88 B | 4.11 B | 3.43 B | 3.48 B | 3.49 B |
Operating Income |
- | - | 1.85 B | 2.3 B | 2.27 B | 3.04 B | 2.36 B | 2.41 B | 2.13 B | - | - | - | - |
Interest Expense |
421 M | 359 M | 344 M | 407 M | 486 M | 438 M | -365 M | -363 M | - | - | - | - | - |
EBITDA |
- | - | 3.48 B | 4.09 B | 3.86 B | 3.83 B | 3.1 B | 3.18 B | 2.76 B | 2.41 B | 2.08 B | 2.09 B | 2.01 B |
Operating Expenses |
- | - | - | 3.36 B | 17 B | 16 B | 17.4 B | 15.3 B | 14.4 B | 13.6 B | 12.4 B | 11.6 B | 10.8 B |
General and Administrative Expenses |
- | - | 3.1 B | 3.16 B | 3.06 B | 2.87 B | 3.58 B | 2.89 B | 2.65 B | 2.17 B | 1.73 B | 1.68 B | 1.83 B |
All numbers in EUR currency
Quarterly Income Statement Fresenius Medical Care AG & Co. KGaA
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | 293 M | - | 293 M | 293 M | 293 M | - | 293 M | 293 M | 298 M | - | 301 M | 303 M | 307 M | - | 306 M | 306 M | 306 M | - | 307 M | 307 M | 307 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
- | - | - | 212 M | - | 331 M | 280 M | 304 M | - | 420 M | 427 M | 350 M | - | 392 M | 315 M | 328 M | - | 349 M | 1.06 B | 330 M | - | 371 M | 338 M | 377 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | 4.55 B | - | 4.44 B | 4.32 B | 4.21 B | - | 4.41 B | 4.56 B | 4.49 B | - | 4.42 B | 4.35 B | 4.13 B | - | 4.06 B | 4.21 B | 3.98 B | - | 4.34 B | 4.47 B | 4.55 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | 3.29 B | - | 3.17 B | 3.04 B | 3 B | - | 3.05 B | 3.14 B | 3.1 B | - | 3.07 B | 3.01 B | 2.87 B | - | 2.79 B | 2.91 B | 2.77 B | - | 2.91 B | 2.98 B | 2.96 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 1.26 B | - | 1.27 B | 1.28 B | 1.21 B | - | 1.36 B | 1.41 B | 1.39 B | - | 1.35 B | 1.33 B | 1.27 B | - | 1.27 B | 1.3 B | 1.2 B | - | 1.42 B | 1.5 B | 1.59 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | 348 M | - | 505 M | 424 M | 474 M | - | 632 M | 656 M | 555 M | - | 595 M | 521 M | 537 M | - | 527 M | 1.4 B | 497 M | - | 609 M | 583 M | 651 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | 105 M | 114 M | -108 M | - | 75.9 M | -84.7 M | -82.9 M | - | -86.1 M | -95 M | -92.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | 767 M | - | 505 M | 424 M | 862 M | - | 632 M | 656 M | 956 M | - | 595 M | 521 M | 899 M | - | 527 M | 1.4 B | 497 M | - | 609 M | 583 M | 651 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | 871 M | - | 731 M | 830 M | 712 M | - | 707 M | 711 M | 810 M | - | 731 M | 795 M | 720 M | - | 743 M | 715 M | 679 M | - | 802 M | 904 M | 923 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency